BamSEC and AlphaSense Join Forces
Learn More

AIM ImmunoTech Inc.

NYSE American: AIM    
Share price (12/20/24): $0.19    
Market cap (12/20/24): $12.1 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.15
from 10-Q 1 page Material contract
12/34/56
EX-10.1
from 8-K 39 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 2 pages Amendment
12/34/56
EX-10.1
from 8-K 2 pages Amendment
12/34/56
EX-10.5
from 10-Q ~1 page Amendment
12/34/56
EX-10.4
from 10-Q ~1 page Amendment
12/34/56
EX-10.1
from 8-K 36 pages Securities Purchase Agreement
12/34/56
EX-10.107
from S-1 ~5 pages Addendum No. 1 to Lease
12/34/56
EX-10.106
from S-1 1 page Material contract
12/34/56
EX-10.105
from 10-K 12 pages Registration Rights Agreement
12/34/56
EX-10.104
from 10-K 25 pages Equity Purchase Agreement
12/34/56
EX-10.2
from 8-K 7 pages Material contract
12/34/56
EX-10.1
from 8-K 17 pages Material contract
12/34/56
EX-10.1
from 8-K 8 pages Amended and Restated Material Transfer and Research Agreement
12/34/56
EX-10.1
from 8-K 6 pages Explanatory Note: [***] Indicates the Portion of This Exhibit That Has Been Omitted Because It Is Both (I) Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed. Material Transfer and Research Agreement
12/34/56
EX-10.1
from 8-K 44 pages AIM ImmunoTech Inc. Up to $8,500,000 Shares of Common Stock Equity Distribution Agreement
12/34/56
EX-10.2
from 8-K 1 page Independent Contractor Services Agreement
12/34/56
EX-10.1
from 8-K 8 pages Unrestricted Grant Agrrement
12/34/56
EX-10.96
from 10-K 1 page Consulting Agreement Term Extension
12/34/56
EX-10.95
from 10-K 5 pages Explanatory Note: [***] Indicates the Portion of This Exhibit That Has Been Omitted Because It Is Both (I) Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed. Co-Ordination Agreement
12/34/56